Candace Carter, PMHNP
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,185 | 52 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ITI, Inc. | $537.18 | 13 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $273.17 | 8 | $0 (2024) |
| ABBVIE INC. | $237.81 | 8 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $208.51 | 4 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $202.85 | 9 | $0 (2022) |
| Alkermes, Inc. | $193.28 | 3 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $157.50 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $145.84 | 1 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $121.19 | 2 | $0 (2023) |
| Corium, LLC | $108.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $478.84 | 18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($208.51) |
| 2023 | $385.78 | 8 | ITI, Inc. ($203.80) |
| 2022 | $959.73 | 21 | ITI, Inc. ($234.34) |
| 2021 | $360.98 | 5 | Neurocrine Biosciences, Inc. ($124.99) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $134.76 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: CNS | ||||||
| 04/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: PSYCHIATRY | ||||||
| 03/28/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: PSYCHIATRY | ||||||
| 03/14/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: PSYCHIATRY | ||||||
| 03/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: PSYCHIATRY | ||||||
| 02/28/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: PSYCHIATRY | ||||||
| 01/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: PSYCHIATRY | ||||||
| 01/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: PSYCHIATRY | ||||||
| 01/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Neuropsychiatry | ||||||
| 11/29/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $145.84 | General |
| Category: Neuroscience | ||||||
| 09/06/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: PSYCHIATRY | ||||||
| 08/16/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Central Nervous System | ||||||
| 08/08/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 44 | 124 | $17,360 | $5,873 |
| 2022 | 4 | 79 | 268 | $36,445 | $15,750 |
| 2021 | 4 | 48 | 99 | $13,298 | $5,757 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 68 | $9,520 | $3,476 | 36.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 11 | 56 | $7,840 | $2,396 | 30.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 15 | 84 | $14,700 | $6,747 | 45.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 14 | 85 | $7,340 | $3,714 | 50.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 66 | $9,240 | $2,817 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 33 | $5,165 | $2,471 | 47.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 33 | $4,980 | $2,511 | 50.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 12 | 26 | $2,756 | $1,209 | 43.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 11 | 20 | $2,761 | $1,084 | 39.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 20 | $2,800 | $953.60 | 34.1% |
About Candace Carter, PMHNP
Candace Carter, PMHNP is a Student in an Organized Health Care Education/Training Program healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2020. The National Provider Identifier (NPI) number assigned to this provider is 1346866829.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Candace Carter, PMHNP has received a total of $2,185 in payments from pharmaceutical and medical device companies, with $478.84 received in 2024. These payments were reported across 52 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,185).
As a Medicare-enrolled provider, Carter has provided services to 171 Medicare beneficiaries, totaling 491 services with total Medicare billing of $27,379. Data is available for 3 years (2021–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Psychiatric/Mental Health
- Location Syracuse, NY
- Active Since 06/22/2020
- Last Updated 08/29/2025
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1346866829
Products in Payments
- CAPLYTA (Drug) $745.69
- VRAYLAR (Drug) $237.81
- LATUDA (Drug) $202.85
- REXULTI (Drug) $172.58
- INGREZZA (Drug) $157.50
- INVEGA SUSTENNA (Drug) $145.84
- AZSTARYS (Drug) $108.00
- ARISTADA (Drug) $107.97
- AUSTEDO (Drug) $100.83
- LYBALVI (Drug) $85.31
- ABILIFY MAINTENA (Drug) $63.96
- ABILIFY ASIMTUFII (Drug) $36.63
- Austedo XR (Drug) $20.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Syracuse
Seokhyun Jin, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $24,625
Dr. Avneet Singh, M.b.b.s, M.B.B.S
Student in an Organized Health Care Education/Training Program — Payments: $16,015
Dr. Rebecca Jameson, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,760
Nelson Sofoluke, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,288
Dr. Tarek Ibrahim, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,187
Dr. David Padalino, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $3,144